Trial intelligence / Profile preview

Efficacy and Safety of Brivaracetam in Partial Onset Seizures

NCT00490035Phase 3Completed

Sponsor
UCB
Start
Sep 2007
Primary completion
Feb 2009
Modality
Small Molecules
Countries
12
01

Overview

A Phase 3 trial of brivaracetam in focal onset seizure, sponsored by UCB. Started Sep 2007; status: completed.

02

Drugs

brivaracetam
03

Conditions

focal onset seizure

Beyond the preview

Go deeper on NCT00490035.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00490035.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call